CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Open-market buy Director bought 15,625 shares at $16.00 ($250,000)
- 4 Open-market buy Director bought 359,375 shares at $16.00 ($5,750,000)
- 4 Open-market buy Director bought 359,375 shares at $16.00 ($5,750,000)
- 4 Open-market buy 10% owner bought 625,000 shares at $16.00 ($10,000,000)
- SC 13D Stake Beneficial Ownership Report
- 4 Conversion 10% owner acquired 681,812 shares (conversion)
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
- 4 Open-market buy 10% owner bought 625,000 shares at $16.00 ($10,000,000)
- SC 13G Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- S-1MEF Other S-1MEF
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 20 of 22 · 423 filings